| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transplantation, Heterologous | 96 | 2024 | 2382 | 11.330 |
Why?
|
| Graft Rejection | 70 | 2024 | 4438 | 5.630 |
Why?
|
| Lung Transplantation | 45 | 2024 | 1310 | 5.390 |
Why?
|
| Body Composition | 136 | 2018 | 2426 | 5.330 |
Why?
|
| Graft Survival | 67 | 2024 | 3814 | 5.020 |
Why?
|
| Heart Transplantation | 61 | 2024 | 3233 | 4.290 |
Why?
|
| Swine | 76 | 2024 | 5908 | 3.520 |
Why?
|
| Galactosyltransferases | 16 | 2022 | 276 | 3.140 |
Why?
|
| Animals, Genetically Modified | 35 | 2024 | 1557 | 2.940 |
Why?
|
| CD40 Ligand | 17 | 2024 | 521 | 2.890 |
Why?
|
| Absorptiometry, Photon | 74 | 2018 | 1738 | 2.290 |
Why?
|
| Papio | 19 | 2024 | 669 | 2.030 |
Why?
|
| Adipose Tissue | 80 | 2018 | 3310 | 1.820 |
Why?
|
| Histamine | 6 | 2022 | 499 | 1.520 |
Why?
|
| Complement System Proteins | 14 | 2023 | 734 | 1.470 |
Why?
|
| Neutron Activation Analysis | 23 | 2003 | 35 | 1.430 |
Why?
|
| Organ Transplantation | 10 | 2022 | 1157 | 1.420 |
Why?
|
| Tissue Donors | 16 | 2024 | 2329 | 1.400 |
Why?
|
| Antibodies | 16 | 2023 | 2413 | 1.400 |
Why?
|
| Immunosuppressive Agents | 24 | 2024 | 4172 | 1.300 |
Why?
|
| Macaca fascicularis | 21 | 2019 | 900 | 1.270 |
Why?
|
| Thrombocytopenia | 8 | 2022 | 1182 | 1.250 |
Why?
|
| Body Water | 45 | 2008 | 340 | 1.170 |
Why?
|
| Lung Injury | 4 | 2017 | 422 | 1.150 |
Why?
|
| Potassium | 45 | 2008 | 1311 | 1.120 |
Why?
|
| Perfusion | 21 | 2023 | 1373 | 1.090 |
Why?
|
| Lung | 20 | 2023 | 9999 | 1.090 |
Why?
|
| Animals | 138 | 2024 | 168202 | 1.070 |
Why?
|
| Heart | 16 | 2022 | 4403 | 1.040 |
Why?
|
| Anthropometry | 29 | 2009 | 1338 | 0.990 |
Why?
|
| Antigens, Heterophile | 3 | 2022 | 70 | 0.930 |
Why?
|
| Tissue and Organ Procurement | 9 | 2024 | 962 | 0.920 |
Why?
|
| Bone Density | 37 | 2010 | 3548 | 0.880 |
Why?
|
| Antibodies, Monoclonal | 14 | 2023 | 9171 | 0.870 |
Why?
|
| Vascular Resistance | 15 | 2018 | 930 | 0.820 |
Why?
|
| Complement Activation | 12 | 2017 | 445 | 0.810 |
Why?
|
| Models, Animal | 5 | 2021 | 2108 | 0.790 |
Why?
|
| Lymphocyte Depletion | 3 | 2017 | 601 | 0.780 |
Why?
|
| Galactose | 1 | 2023 | 294 | 0.770 |
Why?
|
| Heart-Assist Devices | 12 | 2011 | 1288 | 0.770 |
Why?
|
| Endothelial Cells | 5 | 2018 | 3550 | 0.770 |
Why?
|
| Brain Death | 3 | 2024 | 357 | 0.770 |
Why?
|
| Primates | 9 | 2023 | 521 | 0.760 |
Why?
|
| Leukocytes | 4 | 2018 | 2024 | 0.720 |
Why?
|
| von Willebrand Factor | 3 | 2021 | 676 | 0.700 |
Why?
|
| Isoantigens | 2 | 2022 | 551 | 0.700 |
Why?
|
| Body Mass Index | 43 | 2018 | 12942 | 0.700 |
Why?
|
| Body Weight | 51 | 2010 | 4615 | 0.680 |
Why?
|
| Humans | 379 | 2024 | 760740 | 0.670 |
Why?
|
| Expert Testimony | 1 | 2022 | 364 | 0.670 |
Why?
|
| Clinical Trials as Topic | 11 | 2024 | 7995 | 0.660 |
Why?
|
| Blood | 10 | 2014 | 596 | 0.660 |
Why?
|
| Skinfold Thickness | 18 | 2011 | 163 | 0.650 |
Why?
|
| Electric Impedance | 14 | 2005 | 751 | 0.640 |
Why?
|
| Isoantibodies | 8 | 2023 | 669 | 0.640 |
Why?
|
| Complement Inactivator Proteins | 4 | 2007 | 74 | 0.630 |
Why?
|
| Cytomegalovirus Infections | 4 | 2022 | 827 | 0.620 |
Why?
|
| Islets of Langerhans Transplantation | 7 | 2017 | 740 | 0.620 |
Why?
|
| Gene Knockout Techniques | 7 | 2017 | 802 | 0.600 |
Why?
|
| Puberty | 10 | 2006 | 501 | 0.580 |
Why?
|
| Sus scrofa | 3 | 2015 | 428 | 0.570 |
Why?
|
| Transplantation, Heterotopic | 5 | 2012 | 174 | 0.540 |
Why?
|
| Body Constitution | 8 | 2003 | 273 | 0.540 |
Why?
|
| Antigens, CD20 | 2 | 2010 | 199 | 0.530 |
Why?
|
| Patient Selection | 9 | 2024 | 4237 | 0.530 |
Why?
|
| HLA Antigens | 3 | 2022 | 1327 | 0.520 |
Why?
|
| Transplantation, Homologous | 18 | 2023 | 4802 | 0.520 |
Why?
|
| Kidney | 7 | 2024 | 7044 | 0.520 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 1023 | 0.510 |
Why?
|
| E-Selectin | 1 | 2018 | 577 | 0.510 |
Why?
|
| B-Lymphocytes | 6 | 2017 | 4745 | 0.500 |
Why?
|
| Heart-Lung Transplantation | 5 | 2004 | 87 | 0.500 |
Why?
|
| P-Selectin | 1 | 2018 | 599 | 0.500 |
Why?
|
| Cyclosporine | 6 | 2010 | 776 | 0.490 |
Why?
|
| Chagas Disease | 1 | 2016 | 167 | 0.480 |
Why?
|
| Trypanosoma cruzi | 1 | 2016 | 206 | 0.470 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 4 | 2021 | 144 | 0.470 |
Why?
|
| Antibodies, Heterophile | 5 | 2009 | 128 | 0.460 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 7 | 2008 | 65 | 0.450 |
Why?
|
| Kidney Transplantation | 10 | 2024 | 4218 | 0.450 |
Why?
|
| Models, Biological | 37 | 2011 | 9461 | 0.450 |
Why?
|
| Thromboxanes | 4 | 2005 | 45 | 0.440 |
Why?
|
| Heart Diseases | 7 | 2020 | 2778 | 0.440 |
Why?
|
| Sex Characteristics | 20 | 2008 | 2637 | 0.440 |
Why?
|
| Antibody Formation | 6 | 2011 | 1390 | 0.430 |
Why?
|
| Respiratory Insufficiency | 2 | 2017 | 1230 | 0.420 |
Why?
|
| Neutrons | 3 | 2010 | 77 | 0.410 |
Why?
|
| Adiposity | 7 | 2012 | 1879 | 0.410 |
Why?
|
| Carbon | 4 | 2010 | 665 | 0.400 |
Why?
|
| Pulmonary Circulation | 11 | 2007 | 737 | 0.400 |
Why?
|
| Myocardium | 12 | 2010 | 4725 | 0.390 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2022 | 174 | 0.390 |
Why?
|
| Extracellular Space | 18 | 2008 | 562 | 0.390 |
Why?
|
| Acquired Immunodeficiency Syndrome | 13 | 2003 | 2197 | 0.380 |
Why?
|
| Arteriosclerosis | 2 | 2015 | 1056 | 0.380 |
Why?
|
| Nutrition Disorders | 7 | 1991 | 204 | 0.370 |
Why?
|
| Antigens | 3 | 2022 | 1441 | 0.360 |
Why?
|
| Male | 206 | 2024 | 360402 | 0.360 |
Why?
|
| Organ Preservation | 6 | 2019 | 382 | 0.360 |
Why?
|
| Reoperation | 6 | 2017 | 4300 | 0.350 |
Why?
|
| Anemia | 3 | 2016 | 1504 | 0.350 |
Why?
|
| Vascular Diseases | 2 | 2018 | 1159 | 0.340 |
Why?
|
| Blood Platelets | 7 | 2021 | 2478 | 0.340 |
Why?
|
| Female | 205 | 2024 | 392203 | 0.330 |
Why?
|
| Reference Values | 24 | 2007 | 4919 | 0.330 |
Why?
|
| T-Lymphocytes | 13 | 2017 | 10175 | 0.330 |
Why?
|
| Calcium | 12 | 1999 | 5717 | 0.330 |
Why?
|
| Energy Metabolism | 10 | 2010 | 2878 | 0.320 |
Why?
|
| Muscle, Skeletal | 11 | 2009 | 4947 | 0.310 |
Why?
|
| Adult | 156 | 2024 | 220995 | 0.310 |
Why?
|
| Amenorrhea | 4 | 2007 | 483 | 0.310 |
Why?
|
| Epitopes | 2 | 2014 | 2501 | 0.310 |
Why?
|
| Regression Analysis | 29 | 2008 | 6339 | 0.300 |
Why?
|
| Immunomodulation | 1 | 2012 | 548 | 0.300 |
Why?
|
| Influenza A Virus, H2N2 Subtype | 1 | 2007 | 3 | 0.300 |
Why?
|
| Guanidines | 2 | 1999 | 194 | 0.300 |
Why?
|
| Sesquiterpenes | 2 | 1999 | 176 | 0.300 |
Why?
|
| Age Factors | 22 | 2024 | 18381 | 0.290 |
Why?
|
| Health Physics | 1 | 2007 | 32 | 0.290 |
Why?
|
| beta-Thromboglobulin | 1 | 2007 | 20 | 0.290 |
Why?
|
| Hemodynamics | 9 | 2022 | 4160 | 0.290 |
Why?
|
| Middle Aged | 150 | 2024 | 220603 | 0.290 |
Why?
|
| Histocompatibility | 3 | 2017 | 317 | 0.280 |
Why?
|
| Immune Tolerance | 6 | 2009 | 2298 | 0.280 |
Why?
|
| Body Height | 18 | 2010 | 1565 | 0.280 |
Why?
|
| Antilymphocyte Serum | 6 | 2017 | 485 | 0.280 |
Why?
|
| Thrombosis | 6 | 2015 | 2942 | 0.270 |
Why?
|
| Blood Coagulation | 6 | 2014 | 1154 | 0.270 |
Why?
|
| Autoantibodies | 1 | 2015 | 2115 | 0.270 |
Why?
|
| Nutritional Status | 6 | 2010 | 1597 | 0.270 |
Why?
|
| Aorta | 1 | 2014 | 2041 | 0.270 |
Why?
|
| Platelet Aggregation | 3 | 2021 | 771 | 0.270 |
Why?
|
| Antigens, CD | 7 | 2017 | 3998 | 0.270 |
Why?
|
| Genetic Engineering | 1 | 2012 | 931 | 0.260 |
Why?
|
| New York City | 8 | 2015 | 731 | 0.260 |
Why?
|
| Time Factors | 35 | 2024 | 39908 | 0.260 |
Why?
|
| Spinal Cord Injuries | 6 | 2006 | 924 | 0.250 |
Why?
|
| Aging | 18 | 2009 | 8700 | 0.250 |
Why?
|
| Biomedical Research | 3 | 2024 | 3426 | 0.250 |
Why?
|
| Postoperative Complications | 17 | 2020 | 15609 | 0.240 |
Why?
|
| Vimentin | 1 | 2005 | 255 | 0.240 |
Why?
|
| Disaccharides | 4 | 2015 | 170 | 0.240 |
Why?
|
| Transplantation Immunology | 4 | 2015 | 532 | 0.240 |
Why?
|
| Obesity | 26 | 2012 | 12934 | 0.240 |
Why?
|
| Complement C1 Inactivator Proteins | 2 | 2003 | 89 | 0.230 |
Why?
|
| Models, Immunological | 2 | 2015 | 512 | 0.230 |
Why?
|
| Aged | 99 | 2024 | 169092 | 0.230 |
Why?
|
| Tissue Survival | 4 | 2007 | 119 | 0.230 |
Why?
|
| Informed Consent | 4 | 2024 | 1007 | 0.230 |
Why?
|
| Food Preferences | 2 | 2018 | 398 | 0.230 |
Why?
|
| Aurintricarboxylic Acid | 1 | 2003 | 10 | 0.220 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2003 | 30 | 0.220 |
Why?
|
| Congresses as Topic | 2 | 2019 | 802 | 0.220 |
Why?
|
| Awards and Prizes | 1 | 2007 | 360 | 0.220 |
Why?
|
| Transplants | 2 | 2021 | 206 | 0.210 |
Why?
|
| Magnesium | 1 | 2006 | 804 | 0.210 |
Why?
|
| Phantoms, Imaging | 5 | 1999 | 2518 | 0.210 |
Why?
|
| Milk Proteins | 2 | 2001 | 162 | 0.210 |
Why?
|
| Monkey Diseases | 2 | 2016 | 71 | 0.200 |
Why?
|
| Radioisotope Dilution Technique | 7 | 2003 | 71 | 0.200 |
Why?
|
| Mycophenolic Acid | 2 | 2016 | 348 | 0.200 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2003 | 284 | 0.200 |
Why?
|
| Blood Transfusion | 3 | 2016 | 1300 | 0.200 |
Why?
|
| Bioengineering | 1 | 2023 | 99 | 0.200 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2006 | 897 | 0.200 |
Why?
|
| Anticoagulants | 4 | 2015 | 4785 | 0.200 |
Why?
|
| Complement C3a | 3 | 2007 | 66 | 0.200 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 445 | 0.200 |
Why?
|
| Selectins | 1 | 2022 | 101 | 0.200 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2022 | 87 | 0.200 |
Why?
|
| Acute Disease | 12 | 2007 | 7236 | 0.200 |
Why?
|
| Heart Failure | 13 | 2022 | 11670 | 0.200 |
Why?
|
| Tissue Transplantation | 2 | 2015 | 128 | 0.190 |
Why?
|
| Weight Loss | 10 | 2006 | 2682 | 0.190 |
Why?
|
| Blood Group Incompatibility | 1 | 2002 | 133 | 0.190 |
Why?
|
| Research | 4 | 2017 | 1977 | 0.190 |
Why?
|
| Creatinine | 3 | 2006 | 1895 | 0.190 |
Why?
|
| Choice Behavior | 2 | 2018 | 825 | 0.190 |
Why?
|
| Osteopontin | 1 | 2023 | 301 | 0.190 |
Why?
|
| Thoracotomy | 2 | 2006 | 366 | 0.190 |
Why?
|
| Neuraminic Acids | 2 | 2017 | 16 | 0.190 |
Why?
|
| Minerals | 6 | 2002 | 283 | 0.190 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2001 | 57 | 0.190 |
Why?
|
| Coronary Artery Disease | 4 | 2017 | 6403 | 0.180 |
Why?
|
| Dipeptides | 1 | 2003 | 391 | 0.180 |
Why?
|
| Dancing | 1 | 2002 | 104 | 0.180 |
Why?
|
| Paraplegia | 4 | 2003 | 161 | 0.180 |
Why?
|
| Waist-Hip Ratio | 4 | 2012 | 518 | 0.180 |
Why?
|
| Weight Gain | 4 | 2015 | 2349 | 0.180 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2003 | 254 | 0.180 |
Why?
|
| Elements | 6 | 2000 | 21 | 0.180 |
Why?
|
| Swine, Miniature | 2 | 2014 | 961 | 0.180 |
Why?
|
| Respiratory Function Tests | 3 | 2020 | 1683 | 0.180 |
Why?
|
| Oxygen | 2 | 2010 | 4226 | 0.170 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1999 | 56 | 0.170 |
Why?
|
| Aged, 80 and over | 38 | 2012 | 58919 | 0.170 |
Why?
|
| Inflammation | 5 | 2022 | 10759 | 0.170 |
Why?
|
| Hypertension, Pulmonary | 3 | 2005 | 1582 | 0.170 |
Why?
|
| Transplantation Tolerance | 3 | 2018 | 605 | 0.170 |
Why?
|
| Immunoglobulin G | 5 | 2023 | 4533 | 0.170 |
Why?
|
| Neutrophils | 3 | 2018 | 3763 | 0.170 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2017 | 1349 | 0.170 |
Why?
|
| ABO Blood-Group System | 1 | 2002 | 380 | 0.170 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 982 | 0.170 |
Why?
|
| Waiting Lists | 2 | 2004 | 764 | 0.170 |
Why?
|
| Membrane Glycoproteins | 3 | 1999 | 3688 | 0.170 |
Why?
|
| Appetite Stimulants | 1 | 1999 | 14 | 0.170 |
Why?
|
| Immunohistochemistry | 8 | 2012 | 11069 | 0.170 |
Why?
|
| Megestrol Acetate | 1 | 1999 | 18 | 0.170 |
Why?
|
| Bronchi | 2 | 2003 | 846 | 0.170 |
Why?
|
| Saphenous Vein | 4 | 2006 | 516 | 0.160 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 6520 | 0.160 |
Why?
|
| Bromides | 4 | 2008 | 22 | 0.160 |
Why?
|
| Muscles | 9 | 1995 | 1573 | 0.160 |
Why?
|
| Thorax | 1 | 2022 | 555 | 0.160 |
Why?
|
| Birth Weight | 2 | 2015 | 2101 | 0.160 |
Why?
|
| Treatment Outcome | 27 | 2024 | 64572 | 0.160 |
Why?
|
| Myocardial Revascularization | 2 | 2002 | 790 | 0.160 |
Why?
|
| Maryland | 2 | 2017 | 277 | 0.160 |
Why?
|
| Analysis of Variance | 11 | 2006 | 6223 | 0.160 |
Why?
|
| Cytomegalovirus | 2 | 2022 | 748 | 0.160 |
Why?
|
| Fats | 1 | 1999 | 99 | 0.160 |
Why?
|
| Intracellular Fluid | 8 | 2003 | 201 | 0.160 |
Why?
|
| Leptin | 4 | 2007 | 1595 | 0.150 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 95 | 0.150 |
Why?
|
| Radiography, Thoracic | 3 | 2020 | 1302 | 0.150 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 34 | 0.150 |
Why?
|
| Gene Expression | 7 | 2019 | 7569 | 0.150 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 577 | 0.150 |
Why?
|
| Prothrombin | 3 | 2007 | 190 | 0.150 |
Why?
|
| Heart Ventricles | 6 | 2019 | 3796 | 0.150 |
Why?
|
| History, 20th Century | 5 | 2017 | 2764 | 0.150 |
Why?
|
| Platelet Activation | 5 | 2016 | 646 | 0.150 |
Why?
|
| Myocardial Ischemia | 4 | 2005 | 2110 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 2174 | 0.150 |
Why?
|
| Cause of Death | 7 | 2006 | 3683 | 0.150 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 664 | 0.150 |
Why?
|
| Immunoconjugates | 2 | 2007 | 951 | 0.150 |
Why?
|
| Skin Transplantation | 4 | 2001 | 1083 | 0.150 |
Why?
|
| Survival Rate | 12 | 2017 | 12719 | 0.150 |
Why?
|
| Sialic Acids | 1 | 2017 | 123 | 0.140 |
Why?
|
| Iron | 1 | 2006 | 1790 | 0.140 |
Why?
|
| Bone and Bones | 9 | 2003 | 2565 | 0.140 |
Why?
|
| Integrins | 1 | 2022 | 834 | 0.140 |
Why?
|
| Child | 37 | 2024 | 80089 | 0.140 |
Why?
|
| Heme Oxygenase-1 | 2 | 2022 | 366 | 0.140 |
Why?
|
| HIV Infections | 11 | 2007 | 17342 | 0.140 |
Why?
|
| Adolescent | 49 | 2013 | 88247 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2022 | 879 | 0.140 |
Why?
|
| Muscle Development | 1 | 1999 | 259 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2007 | 1521 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2137 | 0.140 |
Why?
|
| Aprotinin | 2 | 2008 | 94 | 0.140 |
Why?
|
| Asia | 4 | 2000 | 616 | 0.140 |
Why?
|
| Whole-Body Counting | 7 | 2003 | 36 | 0.140 |
Why?
|
| Catheters | 1 | 2020 | 423 | 0.140 |
Why?
|
| Cytokines | 4 | 2020 | 7373 | 0.140 |
Why?
|
| Bone Development | 2 | 2001 | 470 | 0.140 |
Why?
|
| Organ Specificity | 1 | 2021 | 1964 | 0.140 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 724 | 0.130 |
Why?
|
| Forecasting | 4 | 2022 | 2924 | 0.130 |
Why?
|
| Ventilator Weaning | 1 | 2017 | 164 | 0.130 |
Why?
|
| New York | 7 | 2012 | 875 | 0.130 |
Why?
|
| Body Fluid Compartments | 4 | 2003 | 50 | 0.130 |
Why?
|
| Deep Sedation | 1 | 2017 | 118 | 0.130 |
Why?
|
| Physiology | 1 | 1996 | 111 | 0.130 |
Why?
|
| Bronchogenic Cyst | 1 | 1995 | 28 | 0.130 |
Why?
|
| Densitometry | 3 | 1991 | 151 | 0.130 |
Why?
|
| Transplantation | 1 | 2017 | 219 | 0.130 |
Why?
|
| Macrophages | 4 | 2023 | 5758 | 0.120 |
Why?
|
| Reproducibility of Results | 14 | 2012 | 20077 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1788 | 0.120 |
Why?
|
| Thrombin | 4 | 2006 | 592 | 0.120 |
Why?
|
| Research Design | 3 | 2024 | 6174 | 0.120 |
Why?
|
| Human Growth Hormone | 1 | 2000 | 642 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2005 | 3621 | 0.120 |
Why?
|
| Narcotics | 1 | 2017 | 335 | 0.120 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1996 | 318 | 0.120 |
Why?
|
| Quadriplegia | 2 | 2003 | 226 | 0.120 |
Why?
|
| Immunogenetics | 1 | 1994 | 62 | 0.120 |
Why?
|
| Indicator Dilution Techniques | 3 | 2008 | 43 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2002 | 1723 | 0.120 |
Why?
|
| Nitrogen | 5 | 1998 | 345 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2018 | 696 | 0.120 |
Why?
|
| Retrospective Studies | 28 | 2024 | 80583 | 0.120 |
Why?
|
| Coronary Vessels | 4 | 2004 | 3095 | 0.120 |
Why?
|
| Renal Insufficiency | 2 | 2016 | 808 | 0.120 |
Why?
|
| Capillary Permeability | 3 | 2006 | 773 | 0.120 |
Why?
|
| Hormones | 2 | 2006 | 869 | 0.120 |
Why?
|
| Gamma Rays | 7 | 2000 | 318 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2007 | 3415 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3045 | 0.120 |
Why?
|
| Nutrition Assessment | 3 | 2003 | 726 | 0.120 |
Why?
|
| History, 21st Century | 4 | 2019 | 1566 | 0.120 |
Why?
|
| Blood Cell Count | 2 | 2007 | 397 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2006 | 537 | 0.110 |
Why?
|
| Renal Dialysis | 4 | 2002 | 1795 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2010 | 693 | 0.110 |
Why?
|
| Sex Factors | 17 | 2008 | 10549 | 0.110 |
Why?
|
| Endothelium, Vascular | 4 | 2015 | 4433 | 0.110 |
Why?
|
| Pregnancy | 6 | 2015 | 29869 | 0.110 |
Why?
|
| Sodium Compounds | 2 | 2008 | 35 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1703 | 0.110 |
Why?
|
| Spine | 2 | 2002 | 1112 | 0.110 |
Why?
|
| Parents | 2 | 2018 | 3563 | 0.110 |
Why?
|
| Cross-Sectional Studies | 24 | 2018 | 26065 | 0.110 |
Why?
|
| Survival Analysis | 8 | 2006 | 10072 | 0.110 |
Why?
|
| Immunoglobulin M | 3 | 2005 | 1526 | 0.110 |
Why?
|
| Child, Preschool | 16 | 2024 | 42193 | 0.110 |
Why?
|
| Anorexia Nervosa | 3 | 2007 | 1361 | 0.110 |
Why?
|
| Radionuclide Imaging | 5 | 1989 | 1972 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1864 | 0.110 |
Why?
|
| Pneumonia | 2 | 2002 | 2143 | 0.110 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1589 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2021 | 3115 | 0.110 |
Why?
|
| Dexmedetomidine | 1 | 2017 | 317 | 0.100 |
Why?
|
| DNA Damage | 1 | 2003 | 2445 | 0.100 |
Why?
|
| Tritium | 7 | 2003 | 706 | 0.100 |
Why?
|
| Immunoglobulins | 2 | 2014 | 850 | 0.100 |
Why?
|
| Follow-Up Studies | 17 | 2017 | 39062 | 0.100 |
Why?
|
| Diet, Reducing | 5 | 2002 | 485 | 0.100 |
Why?
|
| Risk Factors | 14 | 2024 | 74128 | 0.100 |
Why?
|
| United States | 14 | 2024 | 72292 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2023 | 2659 | 0.100 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2014 | 445 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 1923 | 0.100 |
Why?
|
| Bone Resorption | 3 | 2001 | 723 | 0.100 |
Why?
|
| Biological Assay | 1 | 2015 | 626 | 0.100 |
Why?
|
| Pulmonary Artery | 2 | 2022 | 1927 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2006 | 12143 | 0.100 |
Why?
|
| Veterans Health | 1 | 2013 | 215 | 0.100 |
Why?
|
| Eosinophils | 1 | 2016 | 953 | 0.100 |
Why?
|
| Infant | 5 | 2024 | 36157 | 0.100 |
Why?
|
| Osteoporosis | 4 | 2009 | 1604 | 0.100 |
Why?
|
| Running | 3 | 1992 | 488 | 0.100 |
Why?
|
| Cardiac Output | 6 | 1996 | 831 | 0.090 |
Why?
|
| Immunosorbent Techniques | 2 | 2002 | 174 | 0.090 |
Why?
|
| Societies, Scientific | 2 | 2014 | 222 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2012 | 933 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2018 | 3088 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 3 | 2005 | 409 | 0.090 |
Why?
|
| Pericardium | 1 | 1995 | 664 | 0.090 |
Why?
|
| Molecular Biology | 1 | 1994 | 575 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 18220 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2007 | 5109 | 0.090 |
Why?
|
| Parenting | 1 | 2017 | 702 | 0.090 |
Why?
|
| Hematologic Tests | 1 | 2012 | 239 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2506 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2023 | 3743 | 0.090 |
Why?
|
| Corneal Transplantation | 1 | 2014 | 322 | 0.090 |
Why?
|
| Potassium Radioisotopes | 4 | 2008 | 12 | 0.090 |
Why?
|
| Acyclovir | 2 | 2002 | 267 | 0.090 |
Why?
|
| Liver Transplantation | 3 | 2014 | 2328 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9417 | 0.090 |
Why?
|
| Extracorporeal Circulation | 3 | 2017 | 181 | 0.090 |
Why?
|
| Lung Diseases | 2 | 2016 | 1909 | 0.090 |
Why?
|
| Proteins | 9 | 2003 | 6030 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2006 | 1553 | 0.090 |
Why?
|
| Physical Exertion | 3 | 1988 | 668 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1333 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2011 | 565 | 0.080 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 432 | 0.080 |
Why?
|
| Ethics, Medical | 2 | 2000 | 783 | 0.080 |
Why?
|
| Menstruation | 2 | 2007 | 306 | 0.080 |
Why?
|
| Blood Volume | 2 | 2006 | 547 | 0.080 |
Why?
|
| Sensitivity and Specificity | 9 | 2009 | 14649 | 0.080 |
Why?
|
| Hypertriglyceridemia | 2 | 1991 | 293 | 0.080 |
Why?
|
| Lipid Metabolism | 3 | 1995 | 1896 | 0.080 |
Why?
|
| Benzamidines | 2 | 1999 | 20 | 0.080 |
Why?
|
| Rest | 2 | 2010 | 918 | 0.080 |
Why?
|
| Models, Chemical | 1 | 1991 | 611 | 0.080 |
Why?
|
| Heel | 1 | 2009 | 37 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 1213 | 0.080 |
Why?
|
| Aspirin | 5 | 2008 | 3127 | 0.080 |
Why?
|
| Kinetics | 3 | 2015 | 6370 | 0.080 |
Why?
|
| Complement C1 Inhibitor Protein | 2 | 2007 | 97 | 0.080 |
Why?
|
| Exercise | 3 | 2001 | 5886 | 0.080 |
Why?
|
| Mexican Americans | 1 | 2009 | 163 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2474 | 0.080 |
Why?
|
| Calibration | 4 | 2008 | 817 | 0.080 |
Why?
|
| Ganciclovir | 3 | 2002 | 252 | 0.080 |
Why?
|
| Extracellular Fluid | 2 | 2007 | 165 | 0.080 |
Why?
|
| Atrial Fibrillation | 2 | 2023 | 5031 | 0.080 |
Why?
|
| Zoonoses | 1 | 2009 | 179 | 0.080 |
Why?
|
| Quality of Life | 5 | 2023 | 13359 | 0.080 |
Why?
|
| Trace Elements | 1 | 1990 | 195 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3619 | 0.080 |
Why?
|
| Liver | 3 | 2022 | 7512 | 0.080 |
Why?
|
| Transfection | 1 | 1996 | 5765 | 0.070 |
Why?
|
| Fibrinolytic Agents | 3 | 2008 | 2073 | 0.070 |
Why?
|
| Predictive Value of Tests | 9 | 2007 | 15250 | 0.070 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 302 | 0.070 |
Why?
|
| Radioisotopes | 4 | 1991 | 499 | 0.070 |
Why?
|
| Perioperative Care | 2 | 2023 | 1037 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2191 | 0.070 |
Why?
|
| Cryopreservation | 2 | 2004 | 728 | 0.070 |
Why?
|
| Papio anubis | 1 | 2007 | 23 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2009 | 616 | 0.070 |
Why?
|
| Titrimetry | 1 | 2007 | 35 | 0.070 |
Why?
|
| Organisms, Genetically Modified | 1 | 2007 | 63 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4671 | 0.070 |
Why?
|
| Biopsy | 6 | 2007 | 6763 | 0.070 |
Why?
|
| Drug Resistance | 3 | 2008 | 1594 | 0.070 |
Why?
|
| Calcium, Dietary | 2 | 2001 | 529 | 0.070 |
Why?
|
| Warm Ischemia | 1 | 2007 | 58 | 0.070 |
Why?
|
| Organ Size | 6 | 2004 | 2252 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 1995 | 1670 | 0.070 |
Why?
|
| Hemostatics | 2 | 2008 | 240 | 0.070 |
Why?
|
| Cohort Studies | 12 | 2015 | 41464 | 0.070 |
Why?
|
| Erythrovirus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Oxygen Consumption | 5 | 2004 | 1866 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6305 | 0.070 |
Why?
|
| Models, Structural | 3 | 1997 | 340 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2007 | 217 | 0.070 |
Why?
|
| Bones of Lower Extremity | 1 | 2006 | 6 | 0.070 |
Why?
|
| Parvoviridae Infections | 1 | 2006 | 36 | 0.070 |
Why?
|
| Kidney Function Tests | 2 | 2006 | 677 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2007 | 197 | 0.070 |
Why?
|
| Peritoneal Dialysis | 2 | 1998 | 159 | 0.070 |
Why?
|
| Puerto Rico | 2 | 1998 | 378 | 0.070 |
Why?
|
| Coronary Artery Bypass | 3 | 2006 | 2188 | 0.070 |
Why?
|
| Methods | 6 | 1992 | 1065 | 0.070 |
Why?
|
| International Cooperation | 2 | 2009 | 1422 | 0.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 1462 | 0.060 |
Why?
|
| Obesity, Morbid | 4 | 2006 | 1276 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2024 | 26183 | 0.060 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2008 | 507 | 0.060 |
Why?
|
| Lithium | 3 | 1982 | 596 | 0.060 |
Why?
|
| Valine | 1 | 2007 | 408 | 0.060 |
Why?
|
| Receptors, Complement | 2 | 2003 | 253 | 0.060 |
Why?
|
| Dietary Carbohydrates | 1 | 1990 | 891 | 0.060 |
Why?
|
| Thrombophilia | 2 | 2005 | 306 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2802 | 0.060 |
Why?
|
| Complement C4b | 1 | 2005 | 125 | 0.060 |
Why?
|
| Retroviridae | 1 | 2008 | 851 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 1990 | 951 | 0.060 |
Why?
|
| Sex Distribution | 6 | 2012 | 2278 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2009 | 375 | 0.060 |
Why?
|
| Prospective Studies | 16 | 2015 | 54364 | 0.060 |
Why?
|
| Twins, Monozygotic | 3 | 2006 | 470 | 0.060 |
Why?
|
| Risk | 3 | 2009 | 9603 | 0.060 |
Why?
|
| Heparin | 3 | 2007 | 1632 | 0.060 |
Why?
|
| Consensus | 1 | 2014 | 3117 | 0.060 |
Why?
|
| Leukopenia | 1 | 2005 | 213 | 0.060 |
Why?
|
| Estradiol | 3 | 2007 | 1937 | 0.060 |
Why?
|
| Deuterium Oxide | 2 | 2003 | 34 | 0.060 |
Why?
|
| Longitudinal Studies | 8 | 2010 | 14599 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 379 | 0.060 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2006 | 213 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2006 | 1812 | 0.060 |
Why?
|
| Abdominal Fat | 1 | 2006 | 221 | 0.060 |
Why?
|
| Extremities | 3 | 2002 | 867 | 0.060 |
Why?
|
| Medical Illustration | 1 | 2005 | 135 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 564 | 0.060 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2009 | 391 | 0.060 |
Why?
|
| Cells | 2 | 2003 | 164 | 0.060 |
Why?
|
| Malnutrition | 1 | 2010 | 622 | 0.060 |
Why?
|
| Graft vs Host Reaction | 1 | 2003 | 99 | 0.060 |
Why?
|
| Complement C5a | 1 | 2003 | 100 | 0.060 |
Why?
|
| Body Weights and Measures | 2 | 2003 | 208 | 0.060 |
Why?
|
| Algorithms | 6 | 2012 | 14024 | 0.050 |
Why?
|
| Growth | 3 | 2000 | 365 | 0.050 |
Why?
|
| Electrolytes | 2 | 2001 | 274 | 0.050 |
Why?
|
| Blood Physiological Phenomena | 1 | 2003 | 53 | 0.050 |
Why?
|
| Thromboxane B2 | 1 | 2003 | 143 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2007 | 733 | 0.050 |
Why?
|
| Organ Preservation Solutions | 2 | 2019 | 100 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 1810 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 959 | 0.050 |
Why?
|
| Body Fluids | 5 | 1994 | 320 | 0.050 |
Why?
|
| Scedosporium | 1 | 2002 | 10 | 0.050 |
Why?
|
| Arm | 2 | 2006 | 588 | 0.050 |
Why?
|
| Energy Intake | 6 | 2002 | 2133 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2003 | 193 | 0.050 |
Why?
|
| Sodium | 6 | 1992 | 1588 | 0.050 |
Why?
|
| Mycetoma | 1 | 2002 | 18 | 0.050 |
Why?
|
| Erythrocytes | 2 | 2022 | 2410 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2019 | 12759 | 0.050 |
Why?
|
| Mammography | 1 | 2013 | 2430 | 0.050 |
Why?
|
| Intracellular Space | 1 | 2003 | 197 | 0.050 |
Why?
|
| Viscera | 1 | 2003 | 138 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2024 | 323 | 0.050 |
Why?
|
| Autoantigens | 1 | 2007 | 888 | 0.050 |
Why?
|
| Abdomen | 3 | 2003 | 1128 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 281 | 0.050 |
Why?
|
| Bronchial Diseases | 1 | 2003 | 150 | 0.050 |
Why?
|
| Spleen | 2 | 2003 | 2286 | 0.050 |
Why?
|
| Clodronic Acid | 1 | 2022 | 59 | 0.050 |
Why?
|
| Chemokines | 2 | 2018 | 954 | 0.050 |
Why?
|
| Postoperative Hemorrhage | 1 | 2006 | 414 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2019 | 330 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2001 | 50 | 0.050 |
Why?
|
| Head | 1 | 2008 | 922 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2003 | 212 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2007 | 1092 | 0.050 |
Why?
|
| Sternum | 1 | 2002 | 175 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2006 | 2690 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2015 | 18937 | 0.050 |
Why?
|
| Hematocrit | 1 | 2003 | 623 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 2948 | 0.050 |
Why?
|
| Resource Allocation | 1 | 2004 | 350 | 0.050 |
Why?
|
| Young Adult | 7 | 2017 | 59191 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5863 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2005 | 352 | 0.050 |
Why?
|
| Thinness | 1 | 2005 | 480 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2007 | 1250 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2017 | 23974 | 0.050 |
Why?
|
| Lymphocytes | 3 | 2010 | 2604 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2012 | 1496 | 0.050 |
Why?
|
| Histoplasmosis | 1 | 2001 | 63 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2001 | 974 | 0.050 |
Why?
|
| Cardioplegic Solutions | 1 | 2001 | 123 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 2005 | 591 | 0.050 |
Why?
|
| Muscular Atrophy | 2 | 2001 | 334 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 1503 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2002 | 398 | 0.050 |
Why?
|
| Exercise Test | 3 | 1999 | 2127 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 794 | 0.050 |
Why?
|
| Premenopause | 2 | 2003 | 1038 | 0.050 |
Why?
|
| Mannitol | 1 | 2001 | 177 | 0.040 |
Why?
|
| Mediastinal Diseases | 1 | 2001 | 91 | 0.040 |
Why?
|
| Linear Models | 2 | 2004 | 5866 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 424 | 0.040 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 372 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2007 | 991 | 0.040 |
Why?
|
| Wound Infection | 1 | 2002 | 244 | 0.040 |
Why?
|
| Rubidium | 1 | 1980 | 122 | 0.040 |
Why?
|
| Histidine | 1 | 2001 | 308 | 0.040 |
Why?
|
| Cryosurgery | 1 | 2005 | 468 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2005 | 5034 | 0.040 |
Why?
|
| United States Food and Drug Administration | 2 | 2009 | 1661 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2002 | 1835 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2016 | 4642 | 0.040 |
Why?
|
| Peptides | 3 | 2009 | 4354 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 1999 | 1515 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2002 | 299 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2003 | 597 | 0.040 |
Why?
|
| Galactosides | 1 | 1999 | 54 | 0.040 |
Why?
|
| Glutamates | 1 | 2001 | 389 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2006 | 718 | 0.040 |
Why?
|
| Thromboplastin | 2 | 2014 | 286 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2005 | 2635 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2001 | 158 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1700 | 0.040 |
Why?
|
| Sulfates | 2 | 1996 | 379 | 0.040 |
Why?
|
| Hydrocortisone | 3 | 2007 | 1819 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 1096 | 0.040 |
Why?
|
| Lipids | 7 | 1993 | 3332 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 2 | 2015 | 963 | 0.040 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 1999 | 7 | 0.040 |
Why?
|
| Benchmarking | 1 | 2006 | 1045 | 0.040 |
Why?
|
| Cyclophosphamide | 2 | 2002 | 2218 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 3196 | 0.040 |
Why?
|
| Hot Temperature | 2 | 1997 | 1438 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2001 | 552 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1756 | 0.040 |
Why?
|
| Deuterium | 2 | 1996 | 106 | 0.040 |
Why?
|
| Scattering, Radiation | 2 | 1991 | 490 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2001 | 1057 | 0.040 |
Why?
|
| Endocardium | 1 | 2019 | 246 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2003 | 1243 | 0.040 |
Why?
|
| Macaca mulatta | 3 | 2012 | 2328 | 0.040 |
Why?
|
| Glutathione | 1 | 2001 | 582 | 0.040 |
Why?
|
| Vitamin D | 3 | 2009 | 3301 | 0.040 |
Why?
|
| Warfarin | 1 | 2007 | 1477 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2019 | 185 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2003 | 768 | 0.040 |
Why?
|
| Decision Making | 2 | 2017 | 3919 | 0.040 |
Why?
|
| Dogs | 4 | 2007 | 3837 | 0.040 |
Why?
|
| Vascular Patency | 3 | 2006 | 911 | 0.040 |
Why?
|
| Monte Carlo Method | 3 | 1998 | 1257 | 0.040 |
Why?
|
| Texas | 1 | 1999 | 403 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 1009 | 0.040 |
Why?
|
| Italy | 1 | 2000 | 842 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2005 | 767 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2000 | 446 | 0.040 |
Why?
|
| Osteocalcin | 3 | 2007 | 274 | 0.040 |
Why?
|
| Equipment Design | 3 | 2018 | 3501 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 1 | 1998 | 105 | 0.040 |
Why?
|
| Blood Pressure | 7 | 2002 | 8473 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 1 | 2002 | 505 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2007 | 1748 | 0.040 |
Why?
|
| Sucrose | 1 | 1978 | 158 | 0.040 |
Why?
|
| Immobilization | 1 | 1999 | 229 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 908 | 0.040 |
Why?
|
| Tomography | 1 | 2000 | 411 | 0.040 |
Why?
|
| Prednisone | 1 | 2002 | 1562 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1999 | 458 | 0.040 |
Why?
|
| Heart Atria | 1 | 2023 | 1333 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2003 | 909 | 0.040 |
Why?
|
| Registries | 3 | 2005 | 8209 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 2000 | 436 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 1982 | 825 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2007 | 2008 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2001 | 1116 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2007 | 1513 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2001 | 518 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2005 | 1462 | 0.030 |
Why?
|
| Myocardial Infarction | 3 | 2006 | 11458 | 0.030 |
Why?
|
| RNA | 1 | 2006 | 2713 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2894 | 0.030 |
Why?
|
| Thromboxane-A Synthase | 1 | 1996 | 34 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1996 | 113 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 1999 | 432 | 0.030 |
Why?
|
| Receptors, Thromboxane | 1 | 1996 | 30 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1996 | 88 | 0.030 |
Why?
|
| Stroke Volume | 3 | 1989 | 5486 | 0.030 |
Why?
|
| Dyspnea, Paroxysmal | 1 | 1995 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 10754 | 0.030 |
Why?
|
| Shock, Cardiogenic | 1 | 2002 | 709 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1989 | 4365 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 582 | 0.030 |
Why?
|
| Respiration | 4 | 2006 | 1656 | 0.030 |
Why?
|
| Brain | 2 | 2022 | 27100 | 0.030 |
Why?
|
| Body Surface Area | 4 | 2007 | 197 | 0.030 |
Why?
|
| Bromine | 1 | 1975 | 23 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2000 | 1687 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2000 | 1202 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 2409 | 0.030 |
Why?
|
| Physical Education and Training | 1 | 1996 | 102 | 0.030 |
Why?
|
| Methacrylates | 1 | 1996 | 109 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 23415 | 0.030 |
Why?
|
| Basal Metabolism | 2 | 1990 | 161 | 0.030 |
Why?
|
| Self-Assessment | 1 | 1998 | 399 | 0.030 |
Why?
|
| Thrombomodulin | 1 | 2016 | 105 | 0.030 |
Why?
|
| Postmenopause | 2 | 2003 | 2511 | 0.030 |
Why?
|
| Vasculitis | 1 | 1999 | 522 | 0.030 |
Why?
|
| Lectins | 1 | 2017 | 489 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2019 | 785 | 0.030 |
Why?
|
| Isoproterenol | 3 | 1972 | 397 | 0.030 |
Why?
|
| Endothelin-1 | 2 | 2007 | 302 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2789 | 0.030 |
Why?
|
| Gadolinium | 2 | 1991 | 959 | 0.030 |
Why?
|
| Bone Diseases | 1 | 1999 | 418 | 0.030 |
Why?
|
| Longevity | 1 | 2003 | 1064 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1998 | 481 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2007 | 9310 | 0.030 |
Why?
|
| Food Services | 1 | 2018 | 207 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2007 | 731 | 0.030 |
Why?
|
| Platelet Function Tests | 2 | 2007 | 271 | 0.030 |
Why?
|
| Vaccines | 1 | 2003 | 838 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 1999 | 908 | 0.030 |
Why?
|
| Water | 2 | 1978 | 1409 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 1996 | 293 | 0.030 |
Why?
|
| Viral Load | 2 | 2000 | 3325 | 0.030 |
Why?
|
| Primary Graft Dysfunction | 1 | 2015 | 111 | 0.030 |
Why?
|
| Methacholine Compounds | 2 | 1972 | 35 | 0.030 |
Why?
|
| Computer Simulation | 2 | 1998 | 6233 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2006 | 3149 | 0.030 |
Why?
|
| Health Status | 2 | 2001 | 4076 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1973 | 82 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 1991 | 405 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 2003 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 1999 | 1569 | 0.030 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2023 | 1400 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 1148 | 0.030 |
Why?
|
| Arteries | 3 | 2014 | 1120 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2006 | 2917 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2467 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3030 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2003 | 3680 | 0.030 |
Why?
|
| Coronary Disease | 6 | 1996 | 5911 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1999 | 1492 | 0.030 |
Why?
|
| Antithrombins | 1 | 1996 | 292 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 592 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 1993 | 174 | 0.030 |
Why?
|
| Statistics as Topic | 4 | 2005 | 2358 | 0.030 |
Why?
|
| Fluorescence | 1 | 1975 | 756 | 0.030 |
Why?
|
| Environment | 1 | 1999 | 1123 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2001 | 1797 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 1008 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1624 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1884 | 0.030 |
Why?
|
| Photochemotherapy | 2 | 1989 | 823 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2006 | 6390 | 0.030 |
Why?
|
| Mice | 8 | 2023 | 81368 | 0.030 |
Why?
|
| Pancreatitis | 1 | 1999 | 1097 | 0.030 |
Why?
|
| Age Distribution | 3 | 2005 | 2872 | 0.030 |
Why?
|
| Hydrogen | 1 | 1993 | 172 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 1285 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 5463 | 0.020 |
Why?
|
| Colitis | 1 | 2001 | 1234 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 366 | 0.020 |
Why?
|
| Platelet Count | 1 | 1995 | 780 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 1996 | 683 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2003 | 3461 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7390 | 0.020 |
Why?
|
| Ligands | 1 | 1999 | 3268 | 0.020 |
Why?
|
| Serum Albumin, Radio-Iodinated | 2 | 1972 | 37 | 0.020 |
Why?
|
| Fast Neutrons | 1 | 1991 | 18 | 0.020 |
Why?
|
| Cough | 1 | 1995 | 595 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 2011 | 2114 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2013 | 7963 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2002 | 4140 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 395 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1973 | 586 | 0.020 |
Why?
|
| Cell Movement | 1 | 2023 | 5201 | 0.020 |
Why?
|
| Prognosis | 3 | 2007 | 29601 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1597 | 0.020 |
Why?
|
| Sweden | 1 | 2014 | 1379 | 0.020 |
Why?
|
| Sigmoid Neoplasms | 1 | 1970 | 53 | 0.020 |
Why?
|
| Zinc | 1 | 1975 | 687 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 1988 | 0.020 |
Why?
|
| Triolein | 1 | 1990 | 9 | 0.020 |
Why?
|
| Xylose | 1 | 1990 | 28 | 0.020 |
Why?
|
| Critical Care | 1 | 2023 | 2691 | 0.020 |
Why?
|
| Estrone | 2 | 2001 | 234 | 0.020 |
Why?
|
| Home Nursing | 1 | 1990 | 92 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2006 | 20556 | 0.020 |
Why?
|
| Pyridinium Compounds | 2 | 2001 | 81 | 0.020 |
Why?
|
| Specific Gravity | 1 | 1989 | 18 | 0.020 |
Why?
|
| Hypokalemia | 1 | 1970 | 153 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3798 | 0.020 |
Why?
|
| Immersion | 1 | 1989 | 37 | 0.020 |
Why?
|
| Europe | 2 | 2009 | 3415 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1990 | 304 | 0.020 |
Why?
|
| Probability | 2 | 2004 | 2475 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2002 | 3037 | 0.020 |
Why?
|
| Parathyroid Hormone | 3 | 2001 | 1803 | 0.020 |
Why?
|
| Rabbits | 2 | 2000 | 4770 | 0.020 |
Why?
|
| Schools | 1 | 2018 | 1483 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 1990 | 135 | 0.020 |
Why?
|
| Dietary Supplements | 2 | 2001 | 3412 | 0.020 |
Why?
|
| Blood Gas Analysis | 2 | 2006 | 379 | 0.020 |
Why?
|
| Behavior Therapy | 2 | 1992 | 877 | 0.020 |
Why?
|
| Logistic Models | 3 | 2009 | 13248 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 229 | 0.020 |
Why?
|
| Leukapheresis | 1 | 1989 | 134 | 0.020 |
Why?
|
| Amidines | 1 | 1988 | 29 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1991 | 419 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 1988 | 215 | 0.020 |
Why?
|
| Pentamidine | 1 | 1988 | 44 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 11874 | 0.020 |
Why?
|
| Sirolimus | 1 | 2016 | 1533 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 1990 | 400 | 0.020 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1989 | 88 | 0.020 |
Why?
|
| Heart Function Tests | 2 | 2004 | 318 | 0.020 |
Why?
|
| Mathematics | 2 | 1981 | 707 | 0.020 |
Why?
|
| Incidence | 2 | 2024 | 21339 | 0.020 |
Why?
|
| Vaccination | 1 | 2001 | 3370 | 0.020 |
Why?
|
| Asthma | 4 | 1972 | 6234 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 12043 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1982 | 3882 | 0.020 |
Why?
|
| Cardiac Volume | 1 | 1989 | 196 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 464 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1996 | 831 | 0.020 |
Why?
|
| Progesterone | 1 | 1992 | 742 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1736 | 0.020 |
Why?
|
| Computers | 2 | 1985 | 591 | 0.020 |
Why?
|
| Abortion, Induced | 1 | 1973 | 461 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 20988 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 1974 | 680 | 0.020 |
Why?
|
| Aerosols | 4 | 1988 | 635 | 0.020 |
Why?
|
| Blood Circulation Time | 1 | 1966 | 10 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2003 | 2261 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1995 | 901 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2001 | 550 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2007 | 112 | 0.020 |
Why?
|
| Homeostasis | 1 | 1998 | 3321 | 0.020 |
Why?
|
| China | 1 | 1993 | 2374 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2007 | 117 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1991 | 557 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2010 | 282 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1988 | 242 | 0.020 |
Why?
|
| Fatty Liver | 1 | 1993 | 787 | 0.020 |
Why?
|
| Leukocyte Transfusion | 1 | 1986 | 56 | 0.020 |
Why?
|
| Paramyxoviridae | 1 | 2006 | 9 | 0.020 |
Why?
|
| Russia | 1 | 2007 | 382 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1989 | 376 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1990 | 6188 | 0.020 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2006 | 94 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 1999 | 4524 | 0.020 |
Why?
|
| Fetus | 1 | 1973 | 1862 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3599 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 1985 | 67 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2007 | 320 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7583 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1989 | 673 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2008 | 777 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1117 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2006 | 247 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3705 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2006 | 375 | 0.020 |
Why?
|
| Mastectomy | 1 | 2013 | 1817 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1355 | 0.020 |
Why?
|
| Radial Artery | 1 | 2006 | 187 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2007 | 381 | 0.020 |
Why?
|
| Monocytes | 1 | 2014 | 2565 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 726 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2006 | 168 | 0.020 |
Why?
|
| Aerobiosis | 1 | 2004 | 100 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 820 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 2006 | 271 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 1991 | 794 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2018 | 8619 | 0.010 |
Why?
|
| Immune System | 1 | 2010 | 791 | 0.010 |
Why?
|
| Mexico | 1 | 2007 | 757 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 2392 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 539 | 0.010 |
Why?
|
| Sweetening Agents | 1 | 1966 | 290 | 0.010 |
Why?
|
| Homozygote | 1 | 2009 | 1776 | 0.010 |
Why?
|
| Diet | 1 | 2002 | 8049 | 0.010 |
Why?
|
| Absorption | 1 | 1984 | 242 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 4 | 1990 | 22117 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2005 | 108 | 0.010 |
Why?
|
| Alcoholism | 1 | 1975 | 1972 | 0.010 |
Why?
|
| Electrocardiography | 2 | 1989 | 6346 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1981 | 4849 | 0.010 |
Why?
|
| Double-Blind Method | 3 | 2006 | 12333 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2000 | 2567 | 0.010 |
Why?
|
| Lactates | 1 | 2004 | 404 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2006 | 255 | 0.010 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1248 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2006 | 373 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 2003 | 166 | 0.010 |
Why?
|
| Thrombelastography | 1 | 2006 | 187 | 0.010 |
Why?
|
| Azathioprine | 2 | 2000 | 354 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1990 | 1888 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2120 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 2495 | 0.010 |
Why?
|
| Anisotropy | 1 | 2007 | 1283 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2005 | 282 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2722 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 2004 | 338 | 0.010 |
Why?
|
| Spirometry | 3 | 1972 | 928 | 0.010 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 396 | 0.010 |
Why?
|
| Eating | 1 | 1990 | 1535 | 0.010 |
Why?
|
| Ventricular Function, Left | 2 | 2007 | 3873 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3820 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1970 | 834 | 0.010 |
Why?
|
| Microsurgery | 1 | 2008 | 793 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15829 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 935 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 781 | 0.010 |
Why?
|
| Serpins | 1 | 2003 | 247 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2006 | 636 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1624 | 0.010 |
Why?
|
| Licensure, Medical | 1 | 1982 | 71 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 610 | 0.010 |
Why?
|
| Food Deprivation | 1 | 2001 | 114 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1470 | 0.010 |
Why?
|
| Leg | 1 | 2006 | 1087 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2000 | 114 | 0.010 |
Why?
|
| Preoperative Care | 3 | 2000 | 2242 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2009 | 988 | 0.010 |
Why?
|
| Observer Variation | 1 | 2006 | 2607 | 0.010 |
Why?
|
| Serotyping | 1 | 2001 | 325 | 0.010 |
Why?
|
| Temperature | 1 | 2007 | 2224 | 0.010 |
Why?
|
| Comorbidity | 2 | 2006 | 10507 | 0.010 |
Why?
|
| Seasons | 1 | 2006 | 1518 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1985 | 981 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2007 | 1403 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2005 | 805 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3268 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 596 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2007 | 1350 | 0.010 |
Why?
|
| Bipolar Disorder | 2 | 1982 | 5091 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 2000 | 182 | 0.010 |
Why?
|
| Gastroplasty | 2 | 1992 | 157 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 8998 | 0.010 |
Why?
|
| Electron Probe Microanalysis | 1 | 1998 | 32 | 0.010 |
Why?
|
| APACHE | 1 | 1999 | 267 | 0.010 |
Why?
|
| Cerium | 1 | 1998 | 9 | 0.010 |
Why?
|
| Urine | 1 | 2000 | 362 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1998 | 166 | 0.010 |
Why?
|
| Insulin | 4 | 1992 | 6593 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1991 | 3183 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2925 | 0.010 |
Why?
|
| Radioactive Tracers | 1 | 1978 | 66 | 0.010 |
Why?
|
| Nuclear Reactors | 1 | 1998 | 8 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1990 | 913 | 0.010 |
Why?
|
| Sports Medicine | 1 | 1981 | 239 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3776 | 0.010 |
Why?
|
| Emotions | 1 | 1970 | 2741 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1998 | 84 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6418 | 0.010 |
Why?
|
| Somatomedins | 1 | 1998 | 179 | 0.010 |
Why?
|
| Rats | 3 | 1981 | 23716 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1985 | 1028 | 0.010 |
Why?
|
| Mass Screening | 1 | 2013 | 5425 | 0.010 |
Why?
|
| Administration, Oral | 3 | 1992 | 4010 | 0.010 |
Why?
|
| Pelvis | 1 | 2002 | 732 | 0.010 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 396 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2010 | 36401 | 0.010 |
Why?
|
| Infusions, Parenteral | 2 | 1975 | 397 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1998 | 696 | 0.010 |
Why?
|
| Paralysis | 1 | 1999 | 250 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2003 | 2079 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 2006 | 4470 | 0.010 |
Why?
|
| Africa | 1 | 1999 | 714 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2007 | 2977 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2000 | 702 | 0.010 |
Why?
|
| Software | 1 | 1990 | 4432 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 3077 | 0.010 |
Why?
|
| Mesentery | 1 | 1976 | 202 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1406 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1996 | 273 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1662 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1975 | 82 | 0.010 |
Why?
|
| Amino Acids | 1 | 2001 | 1718 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2561 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 730 | 0.010 |
Why?
|
| Thigh | 1 | 1996 | 239 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2005 | 22153 | 0.010 |
Why?
|
| Classification | 1 | 1995 | 127 | 0.010 |
Why?
|
| Ethanol | 1 | 1981 | 1320 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1974 | 9 | 0.010 |
Why?
|
| Radiation Protection | 1 | 1998 | 424 | 0.010 |
Why?
|
| Mitochondria, Liver | 1 | 1975 | 190 | 0.010 |
Why?
|
| Fibrosis | 1 | 2001 | 2047 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4845 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1975 | 172 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 2642 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4569 | 0.010 |
Why?
|
| HIV | 1 | 2000 | 1580 | 0.010 |
Why?
|
| Species Specificity | 2 | 1988 | 2410 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1975 | 1376 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1970 | 6345 | 0.010 |
Why?
|
| Plasma Volume | 1 | 1972 | 31 | 0.010 |
Why?
|
| Pedigree | 1 | 1981 | 4539 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 2634 | 0.010 |
Why?
|
| Jejunoileal Bypass | 1 | 1992 | 13 | 0.010 |
Why?
|
| Personality Tests | 1 | 1992 | 80 | 0.010 |
Why?
|
| Leukemia | 1 | 1981 | 1520 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2000 | 2838 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15577 | 0.010 |
Why?
|
| Glycogen | 1 | 1992 | 251 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1973 | 281 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2001 | 1874 | 0.010 |
Why?
|
| Fetal Death | 1 | 1973 | 435 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1973 | 378 | 0.010 |
Why?
|
| Triglycerides | 2 | 1991 | 2459 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 9476 | 0.010 |
Why?
|
| Chlorides | 1 | 1973 | 665 | 0.010 |
Why?
|
| Carbonates | 1 | 1970 | 21 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 1995 | 561 | 0.010 |
Why?
|
| Injections | 1 | 1973 | 832 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1970 | 180 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2001 | 2090 | 0.010 |
Why?
|
| Constriction | 1 | 1970 | 168 | 0.010 |
Why?
|
| Cell Count | 2 | 1985 | 1834 | 0.010 |
Why?
|
| Chlorine | 1 | 1990 | 57 | 0.010 |
Why?
|
| Atropine | 1 | 1970 | 244 | 0.010 |
Why?
|
| Heart Rate | 3 | 1970 | 4181 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1970 | 325 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 8311 | 0.010 |
Why?
|
| Methoxsalen | 1 | 1989 | 21 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1961 | 3418 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1982 | 3735 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1989 | 216 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2003 | 5074 | 0.000 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 1989 | 91 | 0.000 |
Why?
|
| Colonic Neoplasms | 1 | 1981 | 2533 | 0.000 |
Why?
|
| Methoxamine | 1 | 1968 | 45 | 0.000 |
Why?
|
| Phosphorus | 1 | 1990 | 332 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 212 | 0.000 |
Why?
|
| Escherichia coli | 1 | 2001 | 4210 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1981 | 2223 | 0.000 |
Why?
|
| Receptors, Drug | 1 | 1968 | 157 | 0.000 |
Why?
|
| Thymectomy | 1 | 1988 | 195 | 0.000 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1988 | 139 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1973 | 1670 | 0.000 |
Why?
|
| Major Histocompatibility Complex | 1 | 1990 | 870 | 0.000 |
Why?
|
| Depression | 2 | 1992 | 8132 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1998 | 3567 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 12966 | 0.000 |
Why?
|
| Somatotypes | 1 | 1985 | 41 | 0.000 |
Why?
|
| Administration, Inhalation | 1 | 1988 | 1156 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7847 | 0.000 |
Why?
|
| Epinephrine | 1 | 1968 | 792 | 0.000 |
Why?
|
| Radiometry | 1 | 1970 | 812 | 0.000 |
Why?
|
| Extracellular Matrix | 1 | 1992 | 1718 | 0.000 |
Why?
|
| Gestational Age | 1 | 1973 | 3577 | 0.000 |
Why?
|
| Immunization | 1 | 1989 | 1217 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1981 | 4252 | 0.000 |
Why?
|
| Particle Size | 1 | 1988 | 1648 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1991 | 1300 | 0.000 |
Why?
|
| Steroids | 1 | 1989 | 928 | 0.000 |
Why?
|
| Lipoproteins, LDL | 1 | 1987 | 642 | 0.000 |
Why?
|
| Stroke | 1 | 2006 | 9715 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1989 | 3591 | 0.000 |
Why?
|
| Skin | 1 | 1976 | 4472 | 0.000 |
Why?
|
| Motivation | 1 | 1992 | 2003 | 0.000 |
Why?
|
| Lipoproteins, HDL | 1 | 1987 | 675 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1992 | 2688 | 0.000 |
Why?
|
| Cholesterol | 1 | 1991 | 2902 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1982 | 179 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1986 | 1079 | 0.000 |
Why?
|
| Glucose | 1 | 1992 | 4345 | 0.000 |
Why?
|
| Thyroid Hormones | 1 | 1983 | 403 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1991 | 5239 | 0.000 |
Why?
|
| Radiography | 1 | 1970 | 6961 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4340 | 0.000 |
Why?
|
| Fasting | 1 | 1986 | 1603 | 0.000 |
Why?
|
| Anxiety | 1 | 1992 | 4573 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8516 | 0.000 |
Why?
|
| Angina Pectoris | 1 | 1979 | 959 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1973 | 117 | 0.000 |
Why?
|
| Charcoal | 1 | 1973 | 67 | 0.000 |
Why?
|
| Oxides | 1 | 1973 | 401 | 0.000 |
Why?
|
| Sympatholytics | 1 | 1968 | 82 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1968 | 393 | 0.000 |
Why?
|
| Sympathetic Nervous System | 1 | 1968 | 519 | 0.000 |
Why?
|